Skip to main content

The Dementia Caregiver: Improving their Mental Health and Quality of Life

There are few harder things than being a caregiver for a family member with dementia.   These caregivers are the unsung heroes of the US health system.   Because of family caregivers, 2/3 of persons with dementia are able to continue living at home, often avoiding nursing home care until dementia is very advanced. 

Nursing home care is hugely expensive, and much of the cost in the US is paid by Medicaid.  Next time you hear about how Medicaid nursing home costs are big contributors to federal and state budget crises, remember that without caregivers these costs would at least double. 

But while caregivers of dementia patients are unsung heroes, they are also forgotten heroes.   The US medical system does little to help them.  And they need help.  Dementia caregiving is very stressful and numerous studies have shown negative health consequences in caregivers.  Most prominent is depression.  Caregivers of dementia patients often meet clinical criteria for a diagnosis of major depression. 
This is what makes a recent study in the British Medical Journal (BMJ) so important.  It shows that a pragmatic intervention grounded in counseling and psychological support helps reduce rates of depression in dementia caregivers.  The study was led by Dr. Gill Livingston of University College in London, and based on an intervention protocol developed by Dr. Delores Gallagher-Thompson of Stanford University. 

The study randomized 260 dementia caregivers in London England to the intervention or usual care.  Most of the caregivers were women (70%), either the spouse or an adult child.

The intervention consisted of 8 therapy sessions, usually delivered in the home.  A really neat feature of this intervention:  Psychology graduate students who had no prior clinical experience delivered it.  This nicely supports the feasibility of the intervention as a wide range of persons can be trained to deliver it.

Key features of the intervention, adapted from a manual developed by Dr. Gallagher Thompson were as follows:
  • Teaching caregivers about dementia and helping them understand the behaviors of dementia patients
  • Discussion of behaviors caregivers found difficult and training in behavioral management techniques
  • Teaching skills to help caregivers take better care of themselves such as changing unhelpful thoughts, relaxation techniques, assertive communication, promoting acceptance, and positive reframing
  • Engagement in advance care planning by preparing for future needs
  • Teaching the caregiver to incorporate small pleasant activities into the caregiving day

Caregivers were given “homework” between sessions such as practicing relaxation techniques, identifying triggers and reactions to challenging behaviors, and identifying and challenging negative thoughts.  The caregiver and therapist both worked from a manual, which the caregiver filled out over the course of the intervention.  The intervention showed the following beneficial effects:
  • Caregivers who participated in the intervention had reduced levels of depression and anxiety symptoms
  • Intervention caregivers reported significantly better quality of life
  • The intervention showed a promising trend towards fewer abusive behaviors directed at the caregiver from the family member with dementia

If this intervention were a drug, it would be on the fast track to approval and a pharmaceutical company would be on track to earn billions of dollars.  But alas, it is not a drug.  Therefore, this beneficial program will not be available to the vast majority of dementia caregivers in the US. 
A note to the Alzheimer’s Association: 

Lobbying CMS to pay for this and other proven caregiver support interventions would be a most worthy use of the Association’s advocacy efforts.  Wouldn’t it be best to focus the Association’s advocacy efforts on worthy initiatives that will really benefit Alzheimer patients and caregivers?  This sure seems like a much more worthy advocacy effort than lobbying CMS to pay thousands of dollars a pop for Amyloid PET Scans. 

Shouldn’t we focus on actually helping patients who are living with dementia right now rather than advocating for expensive high tech diagnostics that may lead to more harm than benefit?  (For more discussion, see Eric Widera's GeriPal post and this excellent commentary in the BMJ)

by: Ken Covinsky @geri_doc

Comments

James Murray said…
Great article ...Thanks for your great information, the contents are quiet interesting. I will be waiting for your next post.
Anonymous said…
I agree with this as with the help of caregivers only it is possible to take proper care of the elders and needy people.
Home Healthcare Agency Seminole FL
Anonymous said…
Hi Garipal,

I am a fellow caregiver and just came across your blog - sorry to see you are in the same position, but if you are anything like me I hope your website provides some sort of outlet...

I have been a young(ish!) carer for my mother-in-law, who suffers from dementia, for the last three years now.

I am in the process of creating a new poetry site primarily aimed at carers, but also people with dementia as well - http://dementiapoetry.com.

The blog is an honest account of my experience of caring over the last few years in poems - some silly, some exasperated, some happy, some sad - of my last three years caring for my mother-in-law, who suffers from Alzheimer's disease, and is aimed at helping to support other caregivers in a similar position.

If you would be happy to link to me, I would gladly return the favour!

DG x

Popular posts from this blog

Lost in Translation: Google’s Translation of Palliative Care to ‘Do-Nothing Care’

by: Cynthia X. Pan, MD, FACP, AGSF (@Cxpan5X)

My colleagues often ask me: “Why are Chinese patients so resistant to hospice and palliative care?” “Why are they so unrealistic?” “Don’t they understand that death is part of life?” “Is it true that with Chinese patients you cannot discuss advance directives?”

As a Chinese speaking geriatrician and palliative care physician practicing in Flushing, NY, I have cared for countless Chinese patients with serious illnesses or at end of life.  Invariably, when Chinese patients or families see me, they ask me if I speak Chinese. When I reply “I do” in Mandarin, the relief and instant trust I see on their faces make my day meaningful and worthwhile.

At my hospital, the patient population is about 30% Asian, with the majority of these being Chinese. Most of these patients require language interpretation.  It becomes an interesting challenge and opportunity, as we often need to discuss advance directives, goals of care, and end of life care options…

Elderhood: Podcast with Louise Aronson

In this week's podcast we talk with Louise Aronson MD, MFA, Professor of Geriatrics at UCSF about her new book Elderhood, available for purchase now for delivery on the release date June 11th.

We are one of the first to interview Louise, as she has interviews scheduled with other lesser media outlets to follow (CBS This Morning and Fresh Air with Terry...somebody).

This book is tremendously rich, covering a history of aging/geriatrics, Louise's own journey as a geriatrician facing burnout, aging and death of family of Louise's members, insightful stories of patients, and more.

We focus therefore on the 3 main things we think our listeners and readers will be interested in.

First - why the word "Elder" and "Elderhood" when JAGS/AGS and others recently decided that the preferred terminology was "older adult"?

Second - Robert Butler coined the term ageism in 1969 - where do we see ageism in contemporary writing/thinking?  We focus on Louise's…

Psychedelics: Podcast with Ira Byock

In this week's podcast, we talk with Dr. Ira Byock, a leading palliative care physician, author, and public advocate for improving care through the end of life.

Ira Byock wrote a provocative and compelling paper in the Journal of Pain and Symptom Management titled, "Taking Psychedelics Seriously."

In this podcast we challenge Ira Byock about the use of psychedelics for patients with serious and life-limiting illness.   Guest host Josh Biddle (UCSF Palliative care fellow) asks, "Should clinicians who prescribe psychedelics try them first to understand what their patient's are going through?" The answer is "yes" -- read or listen on for more!

While you're reading, I'll just go over and lick this toad.

-@AlexSmithMD





You can also find us on Youtube!



Listen to GeriPal Podcasts on:
iTunes Google Play MusicSoundcloudStitcher
Transcript
Eric: Welcome to the GeriPal Podcast. This is Eric Widera.

Alex: This is Alex Smith.

Eric: Alex, I spy someone in our …